Tamparong, Danilo S.
HRN: 22-53-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2023
CEFTRIAXONE 1G (VIAL)
03/23/2023
03/30/2023
IV
1g
Q12
Hernia
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes